Antibiotic synergist OM19r reverses aminoglycoside resistance in multidrug-resistant Escherichia coli

INTRODUCTION: The continued emergence and spread of multidrug-resistant (MDR) bacterial pathogens require a new strategy to improve the efficacy of existing antibiotics. Proline-rich antimicrobial peptides (PrAMPs) could also be used as antibacterial synergists due to their unique mechanism of actio...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Qi, Yu, Han-Dong, Xu, Qi-Jun, Liu, Yue, Wang, Yu-Ting, Li, Peng-Hui, Kong, Ling-Cong, Zhang, Hai-Peng, Jiang, Xiu-Yun, Giuliodori, Anna Maria, Fabbretti, Attilio, He, Cheng-Guang, Ma, Hong-Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151501/
https://www.ncbi.nlm.nih.gov/pubmed/37143537
http://dx.doi.org/10.3389/fmicb.2023.1144946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151501/
https://www.ncbi.nlm.nih.gov/pubmed/37143537
http://dx.doi.org/10.3389/fmicb.2023.1144946

Ejemplares similares